Literature DB >> 17107600

The dark side of the NGF family: neurotrophins in neoplasias.

Alex Krüttgen1, Imke Schneider, Joachim Weis.   

Abstract

Although neurotrophins of the nerve growth factor (NGF) family are best known for their neurite outgrowth-inducing and survival-promoting effects on neuronal cells, these are actually pleiotropic growth factors acting physiologically on many different cell types of our body. As for many other growth factors, dysregulation of neurotrophin signal transduction is found in a number of tumors where they can accompany or contribute to malignant transformation. Interestingly, tropomyosin-related kinase (Trk) receptor activation can either support or suppress tumor growth, depending on the tumor type. These same divergent responses have been observed with neurotrophins binding to the p75NTR neurotrophin receptor on tumor cells. This article summarizes the current knowledge on the role of neurotrophins and their receptors in malignancies, with special focus on tumors of neuropathological interest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17107600     DOI: 10.1111/j.1750-3639.2006.00037.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  29 in total

Review 1.  Neurotrophins in lung health and disease.

Authors:  Ys Prakash; Michael A Thompson; Lucas Meuchel; Christina M Pabelick; Carlos B Mantilla; Syed Zaidi; Richard J Martin
Journal:  Expert Rev Respir Med       Date:  2010-06       Impact factor: 3.772

2.  Nerve growth factor links oral cancer progression, pain, and cachexia.

Authors:  Yi Ye; Dongmin Dang; Jianan Zhang; Chi T Viet; David K Lam; John C Dolan; Jennifer L Gibbs; Brian L Schmidt
Journal:  Mol Cancer Ther       Date:  2011-07-12       Impact factor: 6.261

3.  Nerve growth factor suppresses Ehrlich carcinoma growth.

Authors:  A V Osipov; T I Terpinskaya; V S Ulaschik; V I Tsetlin; Y N Utkin
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

4.  Angiostatic effects of K252a, a Trk inhibitor, in murine brain capillary endothelial cells.

Authors:  Shimon Lecht; Hadar Arien-Zakay; Martin Kohan; Peter I Lelkes; Philip Lazarovici
Journal:  Mol Cell Biochem       Date:  2010-02-11       Impact factor: 3.396

5.  Diagnostic value of neurotrophin expression in malignant pleural effusions.

Authors:  Bernard C Duysinx; Astrid Paulus; Vincent Heinen; Delphine Nguyen; Monique Henket; Jean-Louis Corhay; Renaud Louis
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

6.  Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia.

Authors:  Ji-Ping Yang; Huai-Jun Liu; Hua Yang; Ping-Yong Feng
Journal:  Neurol Sci       Date:  2011-03-16       Impact factor: 3.307

Review 7.  NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.

Authors:  Ralph A Bradshaw; Jay Pundavela; Jordane Biarc; Robert J Chalkley; A L Burlingame; Hubert Hondermarck
Journal:  Adv Biol Regul       Date:  2014-11-20

Review 8.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

9.  NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use.

Authors:  Gwen McCaffrey; Michelle L Thompson; Lisa Majuta; Michelle N Fealk; Stephane Chartier; Geraldine Longo; Patrick W Mantyh
Journal:  Cancer Res       Date:  2014-10-06       Impact factor: 12.701

10.  ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.

Authors:  Jing Xiong; Li Zhou; Miao Yang; Yoon Lim; Yu-hong Zhu; Deng-li Fu; Zhi-wei Li; Jin-hua Zhong; Zhi-cheng Xiao; Xin-Fu Zhou
Journal:  Neuro Oncol       Date:  2013-04-10       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.